News

Pfizer CEO: HHS claims of ‘concealed safety concerns’ on mRNA vaccines are ‘completely inaccurate’
Pharmaceutical rivals don’t often come to each other’s defense. But after the US Department of Health and Human Services ...
STAT5d
Pharmalittle: We’re reading about HHS canceling a Moderna contract, FDA rejecting a rare disease drug, and more
In today's Pharmalittle roundup, we're reading about HHS canceling a Moderna contract, FDA rejecting a rare disease drug, and ...
Daily Express US on MSN5d
HHS cancels nearly $766 million Moderna contract on vaccines for bird flu
In a surprising turn, the US health agency has pulled the plug on a major vaccine contract with Moderna, sparking debates on ...
Moderna (MRNA) Faces Multiple Regulatory Challenges
Bloomberg reported that the FDA recently granted Moderna Inc. (NASDAQ:MRNA) a narrower approval for its next-generation COVID ...
C&EN1d
US FDA approves Moderna’s next-generation COVID-19 vaccine, with caveats
The new mRNA vaccine encodes the receptor-binding domain and the N-terminal domain of the SARS-CoV-2 spike protein ...
Moderna Announces Update on Investigational Pandemic Influenza Program
H5 avian flu vaccine study shows positive interim results Company has been notified that HHS will terminate Moderna’s award ...